MLPA® - MRC Holland Kits

Please note before download:

  • Mix descriptions are only free of charge for customers with maintenance contract.
  • Don't hesitate to contact us, if there are any mix descriptions missing on this website.
  • To set up a new mix descriptions for you, still available at MRC Hollands website, please provide us the name of the mix (e.g. P002-D1), the version of the mix (e.g. Vs.02) and the date of its release.

  • To set up a new mix descriptions for you, not available at MRC Hollands website any more, please provide us the corresponding document by email or fax (+49-7822-440150-20).

Download

  • log into your SEQUENCE Pilot installation
  • go to category MLPA®
  • go to operation Mixes [master file]
  • press button [Import] and select the downloaded mme-file
  • if the corresponding mix already exists in your SEQUENE_PILOT installation you will be asked "Do you want to save the mix with a new name / lot?"; please press button [Yes] and complete the fields in the following dialogue; press button [OK] to save your entries
  • if the mix doesn't exist yet just press button [OK] in the following dialogue
MIX
VERSION
DATE
REGION
APPLICATION
DOWNLOAD
MIX
P220-B2
VERSION
Vs. 14
DATE
12-01-2018
REGION
LEPR, POMC, LEP, SIM1, MC3R, MC4R
APPLICATION
Obesity
MIX
P220-B3
VERSION
Vs. B3-01
DATE
18-10-2019
REGION
LEPR 1p31.3; POMC 2p23.3; LEP 7q32.1; SIM1 6q16.3; MC3R 20q13.2; MC4R 18q21.32
APPLICATION
Obesity
MIX
P220-B3
VERSION
Vs. B3-02
DATE
28-07-2022
REGION
LEPR 1p31.3; POMC 2p23.3; LEP 7q32.1; SIM1 6q16.3; MC3R 20q13.2; MC4R 18q21.32
APPLICATION
Obesity
MIX
P221-C1
VERSION
Vs. 11
DATE
18-08-2016
REGION
AIPL1 17p13, CRB1 1q31, CRX 19q13, RPE65 1p31
APPLICATION
Leber congenital amaurosis (LCA)
MIX
P221-C2
VERSION
Vs. C2-01
DATE
27-03-2019
REGION
AIPL1 17p13, CRB1 1q31, CRX 19q13, RPE65 1p31
APPLICATION
Leber congenital amaurosis (LCA)
MIX
P222-B1
VERSION
Vs. 12
DATE
11-03-2016
REGION
GUCY2D 17p13.1, RDH12 14q24, RPGRIP1 14q11, CEP290 12q2
APPLICATION
Leber congenital amaurosis (LCA)
MIX
P222-B2
VERSION
Vs. B2-01
DATE
06-02-2020
REGION
GUCY2D 17p13.1; RDH12 14q24.1; RPGRIP1 14q11.2; CEP290 12q21.32
APPLICATION
Leber congenital amaurosis (LCA)
MIX
P223-B3
VERSION
Vs. 09
DATE
09-05-2016
REGION
PHEX Xp22.2, FGF23 12p13
APPLICATION
Hypophosphatemia, x-linked
MIX
P223-B3
VERSION
Vs. B3-01
DATE
23-03-2020
REGION
PHEX Xp22.11; FGF23 12p13.32
APPLICATION
Hypophosphatemia, X-linked; Hypophosphatemic rickets, autosomal dominant (ADHR)
MIX
P224-B1
VERSION
Vs. 08
DATE
21-12-2012
REGION
PPARG 3p25.1
APPLICATION
Obesity, Diabetes mellitis type II, Familial partial lipodystrophy III, Colon cancer
MIX
P225-E1
VERSION
Vs. E1-01
DATE
19-10-2018
REGION
PTEN 10q23
APPLICATION
Cancer
MIX
P225-E1
VERSION
Vs. E1-02
DATE
10-04-2019
REGION
PTEN 10q23
APPLICATION
Cancer
MIX
P225-E1
VERSION
Vs. E1-03
DATE
29-04-2020
REGION
PTEN 10q23.31
APPLICATION
PTEN hamartoma tumor syndrome, Cowden syndrome, Bannayan-Riley-Ruvalcaba syndrome, PTEN-related proteus syndrome, Proteus-like syndrome
MIX
P225-E1
VERSION
Vs. E1-04
DATE
16-06-2021
REGION
PTEN 10q23.31
APPLICATION
PTEN hamartoma tumor syndrome, Cowden syndrome, Bannayan-Riley-Ruvalcaba syndrome, PTEN-related proteus syndrome, Proteus-like syndrome
MIX
P225-E1
VERSION
Vs. E1-05
DATE
07-06-2022
REGION
PTEN 10q23.31
APPLICATION
PTEN hamartoma tumor syndrome, Cowden syndrome, Bannayan-Riley-Ruvalcaba syndrome, PTEN-related proteus syndrome, Proteus-like syndrome; (Tumour analysis for research use only)
MIX
P226-C1
VERSION
Vs. 18
DATE
29-02-2016
REGION
SDHD 11q23.1, SDHB 1p36.1, SDHC 1q23.3
APPLICATION
Paragangliomas (PGL)
MIX
P226-D1
VERSION
Vs. D1-02
DATE
29-06-2018
REGION
SDHD 11q23.1, SDHB 1p36.1, SDHC 1q23.3
APPLICATION
Paragangliomas (PGL)
MIX
P226-D1
VERSION
Vs. D1-04
DATE
28-09-2020
REGION
SDHD 11q23.1; SDHB 1p36.1; SDHC 1q23.3; SDHAF1 19q13.12; SDHAF2 11q12.2
APPLICATION
Paragangliomas-Pheochromocytoma syndrome, hereditary (PGL/PCC)
MIX
P226-D1
VERSION
Vs. D1-06
DATE
03-02-2022
REGION
SDHD 11q23.1; SDHB 1p36.1; SDHC 1q23.3; SDHAF1 19q13.12; SDHAF2 11q12.2
APPLICATION
Paragangliomas-Pheochromocytoma syndrome, hereditary (PGL/PCC)
MIX
P226-D1
VERSION
Vs. D1-07
DATE
13-09-2022
REGION
SDHD 11q23.1; SDHB 1p36.1; SDHC 1q23.3; SDHAF1 19q13.12; SDHAF2 11q12.2
APPLICATION
Paragangliomas-Pheochromocytoma syndrome, hereditary (PGL/PCC)
MIX
P227-B2
VERSION
Vs. 09
DATE
13-03-2014
REGION
SerpinC1 1q25.1
APPLICATION
Antithrombin (III) deficiency
MIX
P227-B3
VERSION
Vs. 10
DATE
05-10-2017
REGION
SerpinC1 1q25.1
APPLICATION
Antithrombin (III) deficiency
MIX
P227-B4
VERSION
Vs. B4-01
DATE
19-04-2021
REGION
SERPINC1 1q25.1
APPLICATION
Antithrombin III deficiency
MIX
P228-B1
VERSION
Vs. 08
DATE
10-07-2014
REGION
TRPS1 8q24
APPLICATION
Trichorhinophalangeal syndrome type I (TRPS1), Langer-Giedion syndrome (LGS)
MIX
P228-B2
VERSION
Vs. 09
DATE
11-10-2017
REGION
TRPS1 8q24
APPLICATION
Trichorhinophalangeal syndrome type I (TRPS1), Langer-Giedion syndrome (LGS)
MIX
P229-B3
VERSION
Vs. 15
DATE
15-04-2015
REGION
OPA1 3q28, VMD2 11q13, RDS 6p21.2
APPLICATION
Macular dystrophy
MIX
P229-B4
VERSION
Vs. B4-01
DATE
03-07-2018
REGION
OPA1 3q28, VMD2 11q13, RDS 6p21.2
APPLICATION
Macular dystrophy
MIX
P229-B5
VERSION
Vs. B5-01
DATE
18-01-2022
REGION
OPA1 3q29
APPLICATION
Optic atrophy type 1
MIX
P230-B2
VERSION
Vs. 12
DATE
24-06-2015
REGION
9p, 10p, 11p, 12p
APPLICATION
Subtelomeric screening
MIX
P230-B2
VERSION
Vs. 14
DATE
02-03-2018
REGION
9p, 10p, 11p, 12p
APPLICATION
Subtelomeric screening
MIX
P231-B1
VERSION
Vs. 07
DATE
16-10-2013
REGION
FGF10 5p13, FGFR2 10q26
APPLICATION
Autosomal dominant lacrimoauriculodentodigital (LADD)
MIX
P231-B2
VERSION
Vs. 08
DATE
21-10-2016
REGION
FGF10 5p13, FGFR2 10q26
APPLICATION
Autosomal dominant lacrimoauriculodentodigital (LADD)
MIX
P232-C1
VERSION
Vs. 07
DATE
16-12-2012
REGION
FGD1 Xp11.21
APPLICATION
Faciogenital dysplasia (FGDY), Aarskog-Scott syndrome
MIX
P232-C2
VERSION
Vs. C2-01
DATE
09-01-2020
REGION
FGD1 Xp11.21
APPLICATION
Aarskog-Scott syndrome
MIX
P233-B2
VERSION
Vs. 07
DATE
10-09-2013
REGION
MID1 Xp22
APPLICATION
OPITZ syndrome
MIX
P233-B3
VERSION
Vs. 08
DATE
26-07-2017
REGION
MID1 Xp22
APPLICATION
OPITZ syndrome
MIX
P234-A3
VERSION
Vs. 11
DATE
19-09-2016
REGION
GATA4 8p23, GATA3 10p15
APPLICATION
Cardiac septal defects
MIX
P234-A3
VERSION
Vs. 12
DATE
06-04-2018
REGION
GATA3, GATA4
APPLICATION
Cardiac septal defects
MIX
P234-A4
VERSION
Vs. A4-01
DATE
13-07-2020
REGION
GATA4 8p23.1; GATA3 10p14
APPLICATION
Ventricular septal defect-1 (VSD1); Hypoparathyroidism, sensorineural deafness, and renal disease (HDR) syndrome
MIX
P235-B2
VERSION
Vs. 05
DATE
30-01-2014
REGION
RHO 3q21.3, RP1 8q11.2, IMPDH1 7q32, PRPF31 19q13.4
APPLICATION
Retinitis Pigmentosa
MIX
P235-B3
VERSION
Vs. 06
DATE
17-06-2017
REGION
RHO 3q21.3, RP1 8q11.2, IMPDH1 7q32, PRPF31 19q13.4
APPLICATION
Retinitis Pigmentosa
MIX
P235-B3
VERSION
Vs. B3-01
DATE
31-07-2020
REGION
RHO 3q22.1; RP1 8q12.1; IMPDH1 7q32.1; PRPF31 19q13.42
APPLICATION
Retinitis Pigmentosa (RP)
MIX
P236-A3
VERSION
Vs. 15
DATE
12-07-2016
REGION
CFH, CFHR3, CFHR1, CFHR2, 1q23
APPLICATION
Age-related macular degeneration (ARMD)
MIX
P236-A3
VERSION
Vs. A3-01
DATE
06-12-2019
REGION
CFH, CFHR3, CFHR1, CFHR2, 1q31
APPLICATION
Age-related macular degeneration (ARMD)
MIX
P236-A3
VERSION
Vs. A3-02
DATE
17-09-2020
REGION
CFH, CFHR3, CFHR1, CFHR2, 1q31
APPLICATION
Age-related macular degeneration (ARMD)
MIX
P236-B1
VERSION
Vs. B1-01
DATE
17-05-2021
REGION
CFH, CFHR3, CFHR1, CFHR4, CFHR2, CFHR5 1q31
APPLICATION
aHUS, SLE, C3 glomerulopathy
MIX
P236-B1
VERSION
Vs. B1-02
DATE
21-12-2022
REGION
CFH, CFHR3, CFHR1, CFHR4, CFHR2, CFHR5 1q31
APPLICATION
aHUS, SLE, C3 glomerulopathy
MIX
P237-A1
VERSION
Vs. 03
DATE
26-08-2011
REGION
DNAH5 5p15
APPLICATION
Primary ciliary dyskinesia (PCD)
MIX
P237-B1
VERSION
Vs. 06
DATE
26-02-2013
REGION
DNAH5 5p15
APPLICATION
Primary ciliary dyskinesia (PCD)
MIX
P237-B2
VERSION
Vs. B2-01
DATE
26-03-2020
REGION
DNAI1 9p13.3
APPLICATION
Primary ciliary dyskinesia (PCD)
MIX
P238-B1
VERSION
Vs. 09
DATE
14-06-2016
REGION
DNAH5 5p15
APPLICATION
Primary ciliary dyskinesia (PCD)
MIX
P238-B2
VERSION
Vs. B2-01
DATE
03-07-2018
REGION
DNAH5 5p15
APPLICATION
Primary ciliary dyskinesia (PCD)
MIX
P239-B1
VERSION
Vs. 11
DATE
07-03-2016
REGION
BRCA1 region
APPLICATION
Breast cancer
MIX
P239-C1
VERSION
Vs. C1-01
DATE
25-04-2019
REGION
BRCA1 region
APPLICATION
Hereditary breast cancer